by jlohrconsulting | Sep 9, 2025 | Uncategorized
Rheumatol Int. 2025 Sep 9;45(9):225. doi: 10.1007/s00296-025-05984-3. ABSTRACT To identify clinical and demographic predictors associated with the timing of transition from psoriasis (PsO) to psoriatic arthritis (PsA), and to compare the characteristics of patients...
by jlohrconsulting | Sep 9, 2025 | Uncategorized
Eur J Trauma Emerg Surg. 2025 Sep 9;51(1):289. doi: 10.1007/s00068-025-02953-0. ABSTRACT BACKGROUND AND IMPORTANCE: In the Czech Republic, paramedics are required to consult a physician before administering intravenous opioids, which may delay effective prehospital...
by jlohrconsulting | Sep 9, 2025 | Uncategorized
Sex Transm Dis. 2025 Sep 9. doi: 10.1097/OLQ.0000000000002242. Online ahead of print. ABSTRACT BACKGROUND: Men who have sex with men (MSM) and transgender women (TGW) are at elevated mpox risk; vaccination can greatly reduce that risk. We assessed mpox awareness and...
by jlohrconsulting | Sep 9, 2025 | Uncategorized
J Neurol. 2025 Sep 8;272(9):619. doi: 10.1007/s00415-025-13366-9. ABSTRACT INTRODUCTION: Psychological stress has been proposed as a trigger for disease activity in multiple sclerosis (MS), but findings have been inconsistent. While prior research has focused largely...
by jlohrconsulting | Sep 9, 2025 | Uncategorized
Metab Brain Dis. 2025 Sep 9;40(7):262. doi: 10.1007/s11011-025-01680-0. ABSTRACT This study aimed to evaluate the antidepressant potential of Nitazoxanide (NTZ), an antiprotozoal drug with known anti-inflammatory and neuroprotective properties, in a chronic...
Recent Comments